# Effect of Subarachnoid Hyperbaric Bupivacaine in Obese Pregnant Patients Undergoing Cesarean Section

> **NCT06060015** · PHASE4 · UNKNOWN · sponsor: **Hospital Civil de Guadalajara** · enrollment: 106 (estimated)

## Conditions studied

- Anesthesia
- Obstetric Anesthesia Problems

## Interventions

- **DRUG:** 5mg bupivacaine
- **DRUG:** 10mg bupivacaine

## Key facts

- **NCT ID:** NCT06060015
- **Lead sponsor:** Hospital Civil de Guadalajara
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-01
- **Primary completion:** 2024-10-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 106 (ESTIMATED)
- **Last updated:** 2023-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06060015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06060015, "Effect of Subarachnoid Hyperbaric Bupivacaine in Obese Pregnant Patients Undergoing Cesarean Section". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06060015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*